Last reviewed · How we verify

NCT04218383: tDCS

Transcranial Direct Current Stimulation for Impulsivity and Food-related Impulsivity in Obesity

Suspended NA Last updated 15 January 2021
What this trial tests

NA trial testing Transcranial Direct Current Stimulation in Impulsive Behavior in 30 participants. Suspended.

Timeline
3 February 2020
Primary endpoint
30 April 2022
1 November 2022

Quick facts

Lead sponsorUniversity of Calgary
PhaseNA
StatusSuspended
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposebasic science
Enrollment30
Start date3 February 2020
Primary completion30 April 2022
Estimated completion1 November 2022
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University of Calgary

Who can join

Adults 18 to 65, any sex, with Impulsive Behavior. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study the investigators aim to assess whether transcranial direct current stimulation (tDCS; a safe non-invasive method for modulating the activity of specific brain regions) when applied over the orbitofrontal cortex (OFC) is able to modulate impulsivity in obese participants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Transcranial Direct Current Stimulation

Trials testing the same drug.

Other recruiting trials for Impulsive Behavior

Currently open trials in the same condition.

Other University of Calgary trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04218383.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing